Leïla Belkhir
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 16
- SARS-CoV-2 and COVID-19 Research 10
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 5
- Neurology top 5%
- Long-Term Effects of COVID-19 10
- Clinical Biochemistry top 5%
- Virology top 10%
- HIV Research and Treatment 8
-
- Orthopedic Infections and Treatments 6
-
- Infective Endocarditis Diagnosis and Management 6
- Co-authors
- Jean Cyr YombiSophie LeclercqPatrice D. CaniRaphaël EnaudGrégoire WieërsPhilippe de TimaryHector Rodriguez‐VillalobosJulien De Greef
- Journals
- SHILAP Revista de lepidopterología (3 papers)PLoS ONE (2 papers)Scientific Reports (4 papers)
- Partner nations
- BelgiumFranceUnited Kingdom
In The Last Decade
Leïla Belkhir
71 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Infectious Diseases 479
- Neurology 204
- Clinical Biochemistry 74
- Microbiology 7
- Virology 44
Countries citing papers authored by Leïla Belkhir
This map shows the geographic impact of Leïla Belkhir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leïla Belkhir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leïla Belkhir more than expected).
Fields of papers citing papers by Leïla Belkhir
This network shows the impact of papers produced by Leïla Belkhir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leïla Belkhir. The network helps show where Leïla Belkhir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leïla Belkhir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 23 | |
| 10 | 2021 | 18 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 44 | |
| 13 | How Probiotics Affect the Microbiotabreakdown → | 2020 | 382 |
| 14 | 2020 | 20 | |
| 15 | Different patterns of inappropriate antifungals use in daily practice: A single center experience | 2018 | 2 |
| 16 | 2016 | 10 | |
| 17 | 2016 | 6 | |
| 18 | Appropriate prescribing of piperacillin-tazobactam in a teaching hospital | 2013 | 1 |
| 19 | 2013 | 6 | |
| 20 | 2012 | 37 |
About Leïla Belkhir
Leïla Belkhir is a scholar working on Infectious Diseases, Virology and Microbiology, having authored 75 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (10 papers), SARS-CoV-2 and COVID-19 Research (10 papers), HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers), Orthopedic Infections and Treatments (6 papers), Infective Endocarditis Diagnosis and Management (6 papers) and HIV/AIDS Research and Interventions (5 papers). The work is most often cited by research in Infectious Diseases (479 citations), Neurology (204 citations) and Clinical Biochemistry (74 citations). Leïla Belkhir has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Jean Cyr Yombi, Sophie Leclercq, Patrice D. Cani, Raphaël Enaud, Grégoire Wieërs, Philippe de Timary, Hector Rodriguez‐Villalobos, Julien De Greef, Bernard E. Van Beers and Alexia Verroken. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.